North America In Vivo Cro Market Size & Outlook, 2024-2030
North America in vivo cro market, 2018-2030 (US$M)
Related Markets
North America in vivo cro market highlights
- The North America in vivo cro market generated a revenue of USD 2,305.3 million in 2023.
- The market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 2,305.3 million |
| Market revenue in 2030 | USD 3,988.7 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, North America region accounted for 50.0% of the global in vivo cro market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 823.6 million by 2030.
Small molecule was the largest segment with a revenue share of 63.64% in 2024. Horizon Databook has segmented the North America in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
In 2022, North America spearheaded the growth in the global in vivo CRO market. Growth in the region can be attributed to the presence of technologically advanced Contract Research Organizations (CROs) and the increasing number of grants provided by the government organizations, such as the National Institute of Health (NIH), to foster research activities.
The region’s CRO has established a good reputation and demonstrated exceptional performance, making them attractive for research investments during the forecast period. Moreover, extensive drug development activities, the presence of several pharmaceutical & biotech companies, and a surge in clinical trials in the region are some of the factors boosting the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America in vivo cro market size, by country, 2018-2030 (US$M)
North America In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
